Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02779686
What this trial is testing

PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (ARMD)
University of Missouri-Columbia 32
Not applicableStudy completedNCT07420361
What this trial is testing

Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective Study

Who this might be right for
Intermediate Age-Related Macular Degeneration With Reticular Pseudodrusen
Mario Damiano Toro 30
Not applicableStudy completedNCT07648121
What this trial is testing

Assessment of Oral Health-Related Quality of Life in Preschool-Aged Children in Alto Alentejo

Who this might be right for
Oral Health Related Quality of Life (OHRQoL)Early Childhood Caries (ECC)Traumatic Dental Injuries+2 more
University of Lisbon 454
Not applicableStudy completedNCT06174181
What this trial is testing

Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degeneration

Who this might be right for
Dry Eye SyndromesAge-Related Macular Degeneration
Direction Centrale du Service de Santé des Armées 42
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Testing effectiveness (Phase 2)Study completedNCT01494805
What this trial is testing

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more
Lions Eye Institute, Perth, Western Australia 40
Not applicableStudy completedNCT04705805
What this trial is testing

Self-assessment of Olfactory Disorders for French Speaking Patients

Who this might be right for
Post-viral AnosmiaPost-traumatic AnosmiaChronic Rhinosinusitis+2 more
University Hospital, Strasbourg, France 135
Testing effectiveness (Phase 2)Study completedNCT02314299
What this trial is testing

MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaAge-related Macular Degeneration
Stealth BioTherapeutics Inc. 20
Large-scale testing (Phase 3)Looking for participantsNCT07007065
What this trial is testing

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
AbbVie 561
Not applicableStudy completedNCT00001733
What this trial is testing

Screening for Studies on Retinovascular Diseases

Who this might be right for
Diabetic RetinopathyMacular DegenerationPathologic Neovascularization+1 more
National Eye Institute (NEI) 2,000
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Not applicableStudy completedNCT00692887
What this trial is testing

Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 15
Not applicableLooking for participantsNCT07479147
What this trial is testing

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

Who this might be right for
Ischemic StrokeEmbolic Stroke of Undetermined SourcePatent Foramen Ovale (PFO)+1 more
Taichung Veterans General Hospital 400
Not applicableStudy completedNCT02609919
What this trial is testing

Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age

Who this might be right for
Adverse Reaction to DrugAllergic Reaction to Contrast Media
St. Louis University 150
Not applicableLooking for participantsNCT07416799
What this trial is testing

Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment

Who this might be right for
Type2diabetesMild Cognitive ImpairmentAge-related Cognitive Decline
The University of Texas Medical Branch, Galveston 20
Not applicableStudy completedNCT00759044
What this trial is testing

Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function

Who this might be right for
Age-Related MaculopathyDiabetic Macular Edema
Association for Innovation and Biomedical Research on Light and Image 90
Not applicableUnknownNCT05944055
What this trial is testing

25OH Vitamin D Overdoses and Risk of Bronchopulmonary Dysplasia or Death

Who this might be right for
Bronchopulmonary DysplasiaVitamin D Overdose
Hospices Civils de Lyon 173
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Not applicableEnded earlyNCT00347906
What this trial is testing

Photodynamic Therapy (PDT) Versus Transpupillary Thermotherapy (TTT) in Occult Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
University Hospital, Linkoeping
Very early researchStudy completedNCT03478878
What this trial is testing

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

Who this might be right for
Reticular Pseudodrusen (RPD)Age-Related Macular Degeneration
National Eye Institute (NEI) 9
Next Page